65,437 trials
Isolated Focal Hand Dystonia
Primary: Feasibility of Accurately Delivering TMS During the Task of Writing as Measured by Number of Participants Who Completed the TMS Sessions — 12; 12; 11 Participants
Bipolar Disorder · Major Depressive Disorder · Mood Disorders
Primary: Mean Score Measuring Suicidal Ideation/Propensity (SI/P) Using Concise Health Risk Tracking Scale-Self Reported (CHRT-SR) to Assess for Propensity — 12.83; 12.41; 10.84…
Crohn Disease
Primary: Proportion of Patients With Steroid Free Clinical Remission and Fecal Calprotectin<250µg/g at Week 48 — 8; 10 Participants — p=0.5
Esophageal Squamous Cell Carcinoma (ESCC)
Primary: Progression-free Survival (PFS) — 29.0; 28.9 months — p=0.3016
Hepatitis C Virus Infection, Response to Therapy of
Primary: Participants Who Initiate HCV Therapy — 59; 12 Participants — p=<0.001
Injury of Extensor Tendon of Hand · Tendon Adhesions
Primary: Total Active Motion (TAM) of Involved Finger(s) — 232.4; 201.3 degrees
Neurologic Disorder
Primary: Change in Quest Device Score From Baseline to Post-intervention — -1.47 Scores on a scale
Postoperative Wound Infection Superficial Incisional · Postoperative Wound Infection Deep Incisional Surgical Site
Primary: Decrease of Infection Rate as Measured by the Proportion of Subjects With at Least 1 Identified Sternal Infection Within 90 Days Post-cardiac Surgery. — 0; 4.8…
Pain, Acute · Dissociation
Primary: Side Effect Rating Scale for Dissociative Anesthetics (SERSDA) Composite Score — 1.88; 0.42; 1.17; 3.67 Scores on a Scale — p=<0.001
Menkes Disease · Occipital Horn Syndrome
Primary: Treatment Related Adverse Events as Assessed by CTCAE v4.0 — 10; 6 adverse events
Cytomegalovirus (CMV) Infections Among Children and Adult Liver Transplantation Patients in China
Primary: Number of Participants With Clinically Significant CMV Reactivation or CMV Disease — 62; 89; 78; 32 Participants
CAT Intervention Group · Control Group
Primary: Number of Participants Whose Cats Changed From Insecure to Secure Attachment Classification From T1 to T3 — 6; 1 Participants — p=.0156
Stress · Cancer Diagnosis · Distress, Emotional
Primary: Proportion of Enrolled Participants (Feasibility) — 94 Participants
Growth Hormone Deficiency
Primary: Annualized Height Velocity (AHV) Measured as Standing Height With Stadiometer — 0.098 cm/year
Alport Syndrome
Primary: Percentage of Patients With Serious Adverse Events (SAEs) — 1; 0 Participants